IBT
CELG
International Biotechnology Trust’s Celgene Corp CELG Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-171,022
| Closed | -$17M | – | 67 |
|
|
2019
Q3 | $17M | Buy |
171,022
+28,500
| +20% | +$2.83M | 7.85% | 2 |
|
|
2019
Q2 | $13.2M | Sell |
142,522
-93,000
| -39% | -$8.6M | 4.88% | 4 |
|
|
2019
Q1 | $22.2M | Buy |
235,522
+10,000
| +4% | +$943K | 8.21% | 1 |
|
|
2018
Q4 | $11.4M | Sell |
225,522
-28,000
| -11% | -$1.41M | 7.05% | 3 |
|
|
2018
Q3 | $17.4M | Buy |
253,522
+64,000
| +34% | +$4.39M | 8.27% | 1 |
|
|
2018
Q2 | $15.1M | Sell |
189,522
-16,000
| -8% | -$1.27M | 5.78% | 2 |
|
|
2018
Q1 | $18.3M | Buy |
205,522
+15,500
| +8% | +$1.38M | 7.15% | 1 |
|
|
2017
Q4 | $19.8M | Buy |
190,022
+9,500
| +5% | +$992K | 6.99% | 2 |
|
|
2017
Q3 | $26.3M | Buy |
180,522
+3,000
| +2% | +$437K | 10.24% | 1 |
|
|
2017
Q2 | $23.1M | Buy |
177,522
+3,500
| +2% | +$455K | 8.76% | 2 |
|
|
2017
Q1 | $21.7M | Sell |
174,022
-7,700
| -4% | -$958K | 8.29% | 1 |
|
|
2016
Q4 | $21M | Buy |
+181,722
| New | +$21M | 9.48% | 1 |
|